Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
NCT00002259 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To study the toxicity and efficacy of IV mitoxantrone hydrochloride (Novantrone) in AIDS-related Kaposi's sarcoma.
Conditions
- Sarcoma, Kaposi
- HIV Infections
Interventions
- DRUG
-
Mitoxantrone hydrochloride
Sponsors & Collaborators
-
Lederle Laboratories
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
NCT00686842 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir
NCT00362310 ·Status: COMPLETED ·Phase: PHASE2
-
Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
NCT00019123 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT00000954 ·Status: COMPLETED ·Phase: PHASE1
-
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
NCT03157167 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
NCT02029430 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Selumetinib in Patients With Kaposi's Sarcoma
NCT01752569 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00427414 ·Status: TERMINATED ·Phase: PHASE1
-
BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00024024 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma
NCT00000763 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002188 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals
NCT00002189 ·Status: COMPLETED ·Phase: PHASE2
-
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00005042 ·Status: COMPLETED ·Phase: PHASE2
-
Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00002985 ·Status: COMPLETED ·Phase: PHASE3
-
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV
NCT04893018 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002212 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
NCT00002445 ·Status: COMPLETED ·Phase: PHASE3
-
SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment
NCT00005931 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
NCT00004922 ·Status: COMPLETED ·Phase: PHASE2
-
Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus
NCT00025506 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
NCT00000807 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma
NCT01067690 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
NCT00001059 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma
NCT00003719 ·Status: UNKNOWN ·Phase: PHASE2
-
Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus
NCT00025220 ·Status: COMPLETED ·Phase: PHASE2